PRESS RELEASE & TRIAL ACTIVATION: RTOG Foundation Opens New Study Testing [177Lu]Lu-DOTA-TATE for Adults with Meningioma - Read the release: https://ow.ly/BiLA50Xmria - Study info at https://www.rtog.org/Clinical-Trials/Foundation-Studies/3523

In case you missed it, earlier this month we noted just how important our RTOGF Communications Interns are to growing our message! Learn more about our 2025-2026 interns,
Dr. Lee and Dr. Narvaez here: ow.ly/fyva50X7Q2q - Thank you for all you do!

Our RTOGF Interns interviewed Dr. Stephen Chun - Director of Radiation Oncology Clinical Research at MD Anderson Houston area locations and co-founder of the NRG Oncology Podcast - on his career & advice for early career investigators. Read more: ow.ly/PvaF50X7Ttn

This quarter, we have a very jam-packed edition of our RTOGF Newsletter. The Fall 2025 edition can be read here: conta.cc/46OycpI - Not on our mailing list? Email info@rtog.org to be added.

PUB ALERT: Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931 - PubMed Link: pubmed.ncbi.nlm.nih.gov/40680992/

October is #BreastCancer Awareness Month! RTOGF recently reported important results out of the RadComp study for women with non-metastatic breast cancer at #ASTRO25. If you missed it, you can catch up with the press release here: www.rtog.org/News/RadComp...

PUBLICATION ALERT: Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma - PubMed Link: pubmed.ncbi.nlm.nih.gov/40164352/

Want to see a listing of @NRGOnc and RTOG Foundation presentations at #ASTRO25 later this month? Click here to see the full flyer: ow.ly/5oup50WT8vp

September kicks off two very important awareness campaigns: Prostate & Gynecologic Cancer Awareness Month - RTOGF has studies in both disease sites that are collecting data or have reported results. Closed studies & publications can both be found on rtog.org

Pub Alert: Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomy - PubMed link: pubmed.ncbi.nlm.nih.gov/40752653/

Are you an early career investigator looking to learn more about our organization and how to get involved? Mark your calendars! RTOG will be hosting a session at 8:00am at #ASTRO25 in the Early Career & Mentoring Lounge. Come by to network with our RTOGF Leaders.
@ASTRO_org

Interested in learning about the application of RT in benign conditions? A new webinar will occur on Sept 17th, 4:30-5:30PM ET as a part of the ongoing RadOnc Educational Webinar Series. *CME event. Register here: ow.ly/RMsI50WG4F4 Program info: ow.ly/tQRC50WG4F1

Phase III trial of dose escalated radiation therapy and standard androgen deprivation therapy (ADT) vs. dose escalated radiation therapy and enhanced ADT with orteronel for men with high-risk prostate cancer (NRG/RTOG 1115) - PubMed link: pubmed.ncbi.nlm.nih.gov/40712984/

Publication Snapshot: Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy - PubMed: pubmed.ncbi.nlm.nih.gov/40686005/

We are officially one week out on #NRG2025 in Washington, D.C. Will you be attending? What sessions are you most looking forward to?

Do not forget, there are virtual sessions starting today and leading up to the meeting. Check out the agenda: www.nrgoncology.org/Summer2025Mtg

Did You Know? There are several ways you can participate in RTOG Foundation as a member site, an industry collaborator, or by enrolling in one of our studies. Read more on our website about how you can partner with RTOG Foundation. Learn more at rtog.org/Partners

New and updated study documents are added to the CHS-007-01/RTOG 3521 study webpage behind the participating site login. Login at www.rtog.org/Clinical-Tri...

Congratulations to our 2025-2026 RTOG Foundation Communications Interns! We are very thankful to have you as part of our team. Stay tuned for our fall quarterly newsletter to learn more about Drs. Lee and Narvaez-Rojas.

A notice regarding upcoming closures: We will be closed starting at 12pm ET on Thursday, July 3rd and all day on Friday, July 4th in honor of Independence Day (US). We will reopen on Monday, July 7th.

Can you believe #NRG2025 is less than a month away? Dr. Higgins and Dr. Knoll from our RTOGF Communications Committee are hosting a fantastic virtual session on communications & digital engagement. More info below!

In case you missed it, the RTOG Foundation Summer newsletter is now available! Catch up on our new investigator spotlight, our feature on NRG-GI011, and more! conta.cc/3Zx6WcK

Dr. Sameera Kumar is this quarter's RTOG Foundation New Investigator Spotlight! Dr. Kumar is a assistant professor of #radiationoncology at the Fox Chase Cancer Center. Read our interview with Dr. Kumar in her research so far and future goals: www.rtog.org/News/New-Inv...

In our Summer RTOGF newsletter, we shine a spotlight on the NRG-GI011 (LAP100) study assessing dose-escalated #radiationtherapy for locally advanced #pancreaticcancer - Read more details about this study (fixed link!): rtog.org/News/Trial-S...
@NiuSanford

The RTOG Foundation Summer newsletter is now available! Check it out: conta.cc/3Zx6WcK

Publication Snapshot: Embracing the Future of Clinical Trials in Radiation Therapy: An NRG Oncology CIRO Technology Retreat Whitepaper on Pioneering Technologies and AI-Driven Solutions - PubMed: pubmed.ncbi.nlm.nih.gov/39848295/

These results were published in NEJM this morning! Tune in.

Please note the upcoming holiday hours for RTOG Foundation. We will close at 12pm ET on Friday, May 23rd and will reopen on Tuesday, May 27th.

Extended deadline for the RTOG Communications Internship is open until June 16th. More information is available at rtog.org/News/Accepti... - Applications due to info@rtog.org

Today is #ClinicalTrialsDay & the theme is #PoweredByPurpose. We are driven by the purpose to improve the lives of cancer patients & ultimately to one day find a cure for all types of cancer. Thank you to all of our partners, researchers & patients for your endless contributio

Publication Snapshot: Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer published in Clinical Cancer Research - PubMed: pubmed.ncbi.nlm.nih.gov/39656603/